Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-15-368322
Filing Date
2015-11-05
Accepted
2015-11-05 16:18:07
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-1/A d50169ds1a.htm S-1/A 1743872
2 EX-10.9 d50169dex109.htm EX-10.9 183375
3 EX-23.1 d50169dex231.htm EX-23.1 1279
4 GRAPHIC g50169g19e47.jpg GRAPHIC 44326
5 GRAPHIC g50169g34b87.jpg GRAPHIC 94857
6 GRAPHIC g50169g52g11.jpg GRAPHIC 56700
7 GRAPHIC g50169g53b75.jpg GRAPHIC 42738
8 GRAPHIC g50169g69b87.jpg GRAPHIC 53159
9 GRAPHIC g50169g73a33.jpg GRAPHIC 62271
10 GRAPHIC g50169g73u81.jpg GRAPHIC 137161
11 GRAPHIC g50169g89r58.jpg GRAPHIC 47764
12 GRAPHIC g50169g96s79.jpg GRAPHIC 96062
13 GRAPHIC g50169g98u17.jpg GRAPHIC 56070
14 GRAPHIC g50169g98x43.jpg GRAPHIC 73790
  Complete submission text file 0001193125-15-368322.txt   2984776
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-205001 | Film No.: 151200900
SIC: 2834 Pharmaceutical Preparations